Principal Investigator Name: Ronald D. Berger, M.D., Ph.D., F.A.C.C.
Study Coordinator Name: Elizabeth Robinson, R.N.
Contact Phone: (410) 502 - 0517
Study Coordinator
Contact E-mail: erobin26@jhmi.edu
Study Coordinator
Study Short Title: TTOP AF
Study Long Title: Tailored Treatment of Permanent Atrial Fibrillation Trial
IRB Number: JH-eIRB #NA_00011212
Funding Source: Ablation Frontiers, Inc.
Summary of Trial: To investigate the safety and efficacy of the Ablation Frontiers Cardiac Ablation System in the treatment of permanent atrial fibrillation.
Inclusions:
Age between 18 and 70
Patients with non-self-terminating AF lasting greater than seven (7) days but less than four (4) years with at least one failed DC cardioversion within the previous two years
Failure of at least one class I or III rhythm control AAD
Exclusions:
Patients with structural heart disease
Prior ASD or PFO closure with a device using a percutaneous approach
Hypertrophic cardiomyopathy (LV septal wall thickness >1.5 cm)
Any prior ablation for atrial fibrillation
Clinical Trial Site:
Johns Hopkins University
600 N. Wolfe Street, Carnegie 586
Baltimore, MD 21287
Compensation for Participating? No, but parking passes will be distributed to assist with travel expenses.
Start Date: 2008
Anticipated End Date: 2010
